Utama › Kanser (semua jenis) › Alabama › Birmingham
Kajian klinikal Kanser (semua jenis) di Birmingham, AL
30 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Birmingham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Mengambil pesertaFasa 3
- UAB Medicine - UAB Hospital, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 16, Birmingham
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- University of Alabama Birmingham, Birmingham
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Mengambil pesertaFasa 2
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Mengambil pesertaFasa 1/2
- The University of Alabama at Birmingham ( Site 1005), Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Mengambil pesertaFasa 1
- University of Alabama at Birmingham Cancer Center, Birmingham
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Children's Hospital of Alabama, Birmingham
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Mengambil pesertaFasa 2
- Childrens Hospital of Alabama, Birmingham
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- University of Alabama at Birmingham Cancer Center, Birmingham
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 004, Birmingham
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Mengambil pesertaFasa 1
- University of Alabama at Birmingham, Birmingham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Mengambil peserta
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Mengambil pesertaFasa 1
- GSK Investigational Site, Birmingham
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Mengambil peserta
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Multisite Implementation of COMPRENDO
Mengambil pesertaSukarelawan sihat dialu-alukan
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Leading Healthy Eating and Activity Promotion Program
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of Alabama at Birmingham, Birmingham
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Mengambil peserta
- Children's of Alabama at Birmingham, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Mengambil peserta
- University of Alabama at Birmingham, Birmingham
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
Mengambil peserta
- University of Alabama at Birmingham, Birmingham
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Mengambil pesertaKajian pemerhatian
- Alabama Oncology, Birmingham
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
Mengambil peserta
- The Kirklin Clinic, Birmingham
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Alabama Oncology, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Mengambil peserta
- University of Alabama at Brimingham, Birmingham
Making Healthy Habits Stick
Mengambil peserta
- University of Alabama at Birmingham, Birmingham
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
Kajian lain di Birmingham
- Kanser Payudara24 kajian
- Obesiti23 kajian
- Kanser Ovari23 kajian
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Leukemia Mieloid Akut21 kajian
- Mieloma Pelbagai18 kajian
- COPD17 kajian
- Penyakit Kardiovaskular17 kajian
- Berat Badan Berlebihan16 kajian
- Kanser Endometrium16 kajian
- Diabetes Jenis 216 kajian
- Fibrosis Kistik16 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.